Macaulay, V. M., Lord, S., Hussain, S., Maroto, J. P., Jones, R. H., Climent, M. Á., . . . de Bono, J. (2023). A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer. British journal of cancer, 129(6), 965-973. https://doi.org/10.1038/s41416-023-02380-1
Citace podle Chicago (17th ed.)Macaulay, Valentine M., et al. "A Phase Ib/II Study of IGF-neutralising Antibody Xentuzumab with Enzalutamide in Metastatic Castration-resistant Prostate Cancer." British Journal of Cancer 129, no. 6 (2023): 965-973. https://doi.org/10.1038/s41416-023-02380-1.
Citace podle MLA (9th ed.)Macaulay, Valentine M., et al. "A Phase Ib/II Study of IGF-neutralising Antibody Xentuzumab with Enzalutamide in Metastatic Castration-resistant Prostate Cancer." British Journal of Cancer, vol. 129, no. 6, 2023, pp. 965-973, https://doi.org/10.1038/s41416-023-02380-1.